European Vaccine Initiative (EVI)

  This week, we had the pleasure of welcoming the Kintampo Health Research Centre (KHRC) team to European Vaccine Initiative (EVI) in Heidelberg, Germany - a visit that reaffirms a strong and productive collaboration dating back to 2011. Our partnership began with the eICT project, funded by EDCTP, on "Evaluating the impact of malaria clinical trials on the delivery of health care,  particularly for women and children, in sub-Saharan Africa"; and has since flourished, driving impactful research and innovation in infectious disease control. Over the years, we have continued to work together towards advancing vaccine development and global health solutions, demonstrating the power of long-term collaboration.   Thank you to Kwaku Poku Asante, Thomas Gyan, Abdul Karimu Alhassan, Martin Dzimabi for the fruitful discussions and insights into strengthening partnerships. We look forward to many more years of impactful work together! 🤝

The #PrIMAVeRa_AMR consortium celebrates the acceptance of its newly produced video 📽️ to be presented at #ESCMIDGlobal Event 2025 in Vienna! This video gives an accessible introduction to the project’s goals and methods, and includes interviews with key partners including: -       Dr. Irina Meln, PhD, Project Coordinator, of the European Vaccine Initiative (EVI) Vaccine Initiative -       Dr. Marc Bonten, Scientific Lead, of the UMC Utrecht -       Dr. Venanzio Vella, EFPIA - European Federation of Pharmaceutical Industries and Associations Lead, of GSK Vaccines 📝Read more, and view the video here: https://lnkd.in/dn5DJaGb By lowering the occurrence of infectious diseases, reducing the reliance on #antibiotics, and limiting the development of #AMR within communities, #vaccines can serve as a crucial tool in combating and managing AMR, and ultimately #savelives. --- #Eufunded #StopSuperbugs #StopSuperbugs Innovative Health Initiative (IHI), AMR Accelerator  ESCMID - European Society of Clinical Microbiology and Infectious Diseases

Welcome Dr Zakariah Buwah at the European Vaccine Initiative (EVI) through the WHO-TDR Clinical Research Leadership Programme! Dr. Buwah brings valuable experience in clinical trials and #vaccine research, having worked on #malaria, COVID-19, Lassa fever, and sickle cell treatments. As a WANETAM-trained clinical trialist sponsored by EDCTP, he has also contributed to yellow fever vaccine research at MRC Gambia. He holds a Master’s in Public Health from the University of Ghana, Legon. Dr Buwah is eager to expand his expertise in clinical trial design, vaccine development, and #projectmanagement. Join us to welcome Dr Zakariah Buwah to the EVI team! —- https://lnkd.in/eXHd5kd9

We are happy to welcome our new research fellow, Dr Samiratu Yakubu! With 7 years in #clinicaltrials regulation and GCP, she brings expertise in #vaccine development and regulatory oversight. Dr. Yakubo is affiliated with the Food and Drug Authority, Ghana, and holds a master’s in clinical Drug Development from University College London. At European Vaccine Initiative (EVI) she aims to strengthen her knowledge in multi-national vaccine development, regulatory submissions, and stakeholder coordination to support vaccine trials in Ghana. Join us to welcome Dr Samiratu Yakubo to the EVI team. — https://lnkd.in/dKd4AEfR

🌍 We’re thrilled to share that the CAPTIVATE Annual Meeting successfully took place on 20-21 February 2025! CAPTIVATE partners and SEAC members came together to reflect on project achievements and shape future directions. A special highlight was hearing from our distinguished keynote speakers: 🎤 Lindsey Wu (World Health Organization) 🎤 Paul Thomas (St. Jude Children's Research Hospital, US) As we move forward, we remain dedicated to developing a new multistage #malaria #vaccine, driving innovation, and strengthening global health efforts. --- PROJECT PARTNERS Leiden University Medical Center DKFZ German Cancer Research Center ImmuneWatch NEC OncoImmunity AS Quantoom Biosciences BPRC UNSW --- #CaptivateEu #MalariaVaccine #EUFunded 🔗 Read more about the project here: captivate-malaria.eu This project has received funding from the European Union’s Horizon Europe research and innovation programme under grant agreement No 101081028.

Ole Olesen, European Vaccine Initiative (EVI)’s Executive Director, discussed the future funding for global health in the EU framework programme, making the case for continued European investment in the development of #vaccines for diseases of neglected populations, such as #malaria and #tuberculosis. 🦟🦠   🎯 Read the key highlights of the Science|Business session hosted by Impact Global Health and Deutsche Stiftung Weltbevoelkerung (DSW): https://lnkd.in/dnc3EX4Q

For decades, the World Health Organization has worked with countries to #EndMalaria — 45 countries and 1 territory have been successful so far! Hope towards a malaria-free world is rising with 25 of 83 endemic countries now reporting fewer than 10 cases per year. #HealthForAll

On February 7th, 2025, our colleague Mandeep Kaur had the opportunity to present European Vaccine Initiative (EVI) led research on 'Acceptability of Placental Malaria vaccines in Malawi as a case study' in the Public Health Anthropology (PHA) course at Heidelberg Institute of Global Health (HIGH) for MSc International Health students. 🦟🌍 “It was a privilege to engage with such a dynamic group of future global health professionals, discussing key insights into maternal health, vaccine perceptions, and the challenges of translating research into impact. Engaging with the course participants was both inspiring and thought-provoking.”, said Mandeep. This wouldn’t have been possible without the support of Dr Jonas Wachinger and Dr Aurélia Souares whose support and encouragement have been invaluable. We truly appreciate the collaboration and look forward to more opportunities to work together in the future. A big thank you to everyone involved! --- #GlobalHealth #MaternalHealth #VaccineAdvocacy 🎯 Read more about this study: https://lnkd.in/eiATiMVq

On the 10th anniversary of International Day of Women and Girls in Science, we honor the remarkable contributions of #women in the fields of science, technology, engineering, and mathematics (#STEM). Their dedication and innovation have been instrumental in advancing our understanding of the world. The Global #GenderGap Report 2023 indicates that women only make up 29.2% of the STEM workforce in the 146 countries, compared to nearly 50% of non-STEM occupations (https://lnkd.in/dkENF8b8). To close the gender gap in science, we need to break down stereotypes and promote role models to inspire young girls.  --- We are proud to say that at European Vaccine Initiative (EVI) women represent more than half of the team, contributing their expertise, education, and diverse viewpoints. Let's continue to support and inspire the next generation of female scientists, ensuring that diversity and inclusion remain at the forefront of scientific progress. --- #WomenInScience #STEM #DiversityInSTEM #PublicHealth 

As the EU-funded VACCELERATE_EU project comes to an end, we celebrate its incredible achievements in #vaccineResearch! 🌍 Built a Pan-European clinical trial network 💉 Accelerated vaccine trials during COVID-19 📢 Engaged the public through a Volunteer Registry 📑 Standardised data & protocols 👩🔬 Trained experts & strengthened pandemic readiness 👴🏾 Advanced public health by studying under-researched groups The infrastructure and knowledge built through this project will continue to provide invaluable support in the years ahead, ensuring a strong foundation for future initiatives. Thank you to all partners who made this journey possible. 🙌 Read more: https://lnkd.in/d9QmSCHa #EUcollaboration #GlobalHealth #VACCELERATE